Chen, Yu-Li <br/><br/>
Interferon-gamma in ascites could be a predictive biomarker of outcome in ovarian carcinoma.  [electronic resource] 

 -  Gynecologic oncology  Oct 2013 
 - 63-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-6859 
<br/><br/><label>Standard No.: </label>10.1016/j.ygyno.2013.07.105  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Ascites--etiology<br/>Biomarkers, Tumor--metabolism<br/>Carcinoma--complications<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Interferon-gamma--metabolism<br/>Middle Aged<br/>Neoplasm Grading<br/>Ovarian Neoplasms--complications<br/>Proportional Hazards Models